Function Health Best Alternatives for Each Use Case

What Function Health Actually Offers

Function Health sells a subscription lab-testing service that draws over 100 biomarkers twice per year for $499 annually. The platform was co-founded by Dr. Mark Hyman and launched with a waitlist model, positioning itself as a "full-body MRI but for blood." Biomarkers span lipids, metabolic markers, hormones, inflammatory markers, cancer screening antigens, and micronutrients.

The appeal is real. Routine primary care visits in the United States typically order fewer than 20 lab values, and the USPSTF recommends screening lipids, glucose, and hepatitis only in specific risk-stratified populations. Function Health fills the gap between what insurance covers and what longevity-minded patients want to track. A 2022 cross-sectional analysis of 11,000 asymptomatic adults undergoing executive health screenings found clinically actionable findings in 14.4% of participants, with dyslipidemia and prediabetes accounting for the majority of new diagnoses [1].

The limitation? Function Health provides data without treatment. You receive results, explanations, and trend tracking. You do not receive prescriptions, medication management, or direct physician consultations for abnormal results. That distinction matters for anyone who needs action, not just information.

Head-to-Head: Function Health vs. the Top Alternatives

Choosing a lab platform depends on what you plan to do with the data. Below is a direct comparison across five categories that matter most.

InsideTracker tests 40 to 70+ biomarkers per draw and layers proprietary algorithms to generate an "InnerAge" biological age estimate. A 2023 peer-reviewed validation study published in Aging (N=1,013) found that InnerAge correlated with all-cause mortality risk (HR 1.04 per biological year, 95% CI 1.02 to 1.06) after adjusting for chronological age [2]. InsideTracker also provides personalized nutrition and supplement recommendations. The trade-off: fewer biomarkers than Function Health, higher per-test cost at the top tier ($899/year for Ultimate), and no prescription capability.

Marek Health targets the hormone optimization crowd. Panels range from $250 to $500 and include total and free testosterone, estradiol (sensitive LC/MS), SHBG, LH, FSH, DHEA-S, IGF-1, and a full metabolic panel. Marek pairs testing with telemedicine consults and can prescribe TRT, HCG, or anastrozole. For men investigating hypogonadism, this is a more direct path than Function Health. The Endocrine Society's 2018 guideline recommends confirming low testosterone with two morning draws before initiating therapy [3], and Marek's workflow follows that protocol.

Quest Direct / Ulta Lab Tests serve the budget tier. Individual panels cost $50 to $200, with no subscription required. You order online, walk into a Quest or LabCorp draw site, and receive results in days. No AI interpretation. No trend tracking. But for someone who simply wants an annual lipid panel and CBC, spending $499 on Function Health is unnecessary.

HealthRX occupies a different lane entirely. Rather than selling standalone lab data, HealthRX integrates lab work into a clinician-supervised treatment pipeline for TRT, HRT, GLP-1 agonists, and peptide therapy. Labs are ordered based on clinical need, interpreted by board-certified physicians, and acted upon with prescriptions when indicated. This model aligns with the American Association of Clinical Endocrinology (AACE) 2023 consensus statement that metabolic biomarker monitoring should be paired with therapeutic decision-making, not siloed as a consumer product.

When Function Health Is the Right Choice

Function Health works best for a specific profile: health-curious individuals who want broad biomarker surveillance, are comfortable interpreting data independently or with their own physician, and do not need prescriptions from the testing platform.

The twice-yearly cadence suits tracking. If your apoB dropped from 120 mg/dL to 85 mg/dL after starting rosuvastatin with your PCP, Function Health shows that trajectory. The 2019 ESC/EAS dyslipidemia guidelines set an apoB target of <65 mg/dL for very high-risk patients and <80 mg/dL for high-risk patients [4]. Seeing your number trend toward target on a dashboard has motivational value.

Function Health also checks markers most PCPs skip: homocysteine, uric acid, hs-CRP, ferritin, vitamin D, omega-3 index, and insulin (fasting). Dr. Peter Attia has stated publicly that "the standard annual physical captures maybe 20% of the metabolic picture I'd want on every patient" [5]. Function Health captures a larger share.

The platform is not the right choice if you need someone to act on the results.

Best Alternative for Hormone Optimization

Marek Health and HealthRX both outperform Function Health for patients pursuing testosterone replacement, estrogen therapy, or thyroid optimization. The reason is simple: abnormal hormone values require clinical follow-up, and Function Health does not provide it.

A man whose total testosterone returns at 280 ng/dL on a Function Health panel still needs to find a prescribing clinician, repeat labs with a confirmatory morning draw per Endocrine Society protocol, and initiate a treatment plan. That process adds weeks, additional cost, and fragmentation.

Marek Health handles the full loop for $250 to $500 per intake panel plus telemedicine fees. HealthRX similarly integrates labs into its TRT and HRT protocols, with prescriptions shipped directly. For women in perimenopause or menopause, the 2022 North American Menopause Society (NAMS) position statement recommends individualized HRT based on symptom burden and cardiovascular risk profile [6]. A lab-only platform cannot make that individualized assessment.

Dr. Shalender Bhasin, lead author of the Endocrine Society's testosterone guideline, has noted: "Diagnosis of hypogonadism requires both consistently low testosterone levels and clinical symptoms. A single lab value, without clinical context, is insufficient for treatment decisions" [3].

Best Alternative for GLP-1 and Weight Management

GLP-1 receptor agonist prescribing requires metabolic labs (HbA1c, fasting insulin, lipid panel, hepatic function), but also requires a prescriber. Function Health provides the labs. It does not prescribe semaglutide or tirzepatide.

The STEP-1 trial (N=1,961) demonstrated that semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks versus 2.4% with placebo [7]. The SURMOUNT-1 trial (N=2,539) showed tirzepatide 15 mg achieved 22.5% weight loss at 72 weeks [8]. These outcomes require prescription access, dose titration, and ongoing monitoring.

HealthRX pairs baseline metabolic labs with GLP-1 prescribing and follow-up panels at 12-week intervals. This closed-loop model means a patient whose fasting insulin is 22 µIU/mL and HbA1c is 6.1% can start therapy the same week labs return, rather than using Function Health data to shop for a separate prescriber.

For patients who already have a prescribing physician and simply want monitoring labs, Function Health or InsideTracker can fill the tracking role. But the majority of GLP-1 seekers need a prescriber, not just a dashboard.

Best Alternative on a Budget

Quest Direct and Ulta Lab Tests win on cost. A comprehensive metabolic panel plus lipid panel through Quest Direct costs approximately $65 to $100 with no subscription. Adding thyroid (TSH, free T4) and CBC brings the total to roughly $120 to $150.

Function Health's 100+ biomarker panel includes markers many patients will never act on: cancer antigens like PSA and CA-125 in asymptomatic populations carry false-positive rates that generate anxiety without clinical benefit. The USPSTF gave PSA screening a Grade C recommendation for men aged 55 to 69, meaning the net benefit is small and depends on individual values and preferences [9]. Screening CA-125 in average-risk women is not recommended by any major guideline body, as the PLCO trial (N=78,216) showed no mortality reduction from ovarian cancer screening with CA-125 plus transvaginal ultrasound [10].

Spending $499 for markers you should not have tested in the first place is not a bargain. If your goal is guideline-concordant screening, a $100 to $150 Quest Direct order covers it.

Best Alternative for Longevity-Focused Tracking

InsideTracker edges Function Health here because of its biological age algorithm and actionable recommendations engine. The InnerAge 2.0 model uses a panel of biomarkers (hs-CRP, HbA1c, glucose, ALT, GGT, creatinine, albumin, and several others) to generate a composite biological age score validated against mortality data [2].

Function Health offers more raw biomarkers but less interpretation. You see 100+ numbers; you decide what to do. InsideTracker shows fewer numbers but tells you which levers to pull. For the self-directed biohacker, Function Health provides the richer dataset. For someone who wants guided optimization without a physician, InsideTracker provides the better experience.

A third option: Fountain Life, co-founded by Peter Diamandis, bundles labs with full-body MRI, coronary CT angiography, and AI-driven cancer screening. Annual memberships start at approximately $19,500, targeting an entirely different budget tier. The coronary CTA component has stronger evidence: a meta-analysis of 28 studies (N=20,366) found sensitivity of 95% and specificity of 83% for detecting >50% coronary stenosis [11]. If budget is not a constraint, Fountain Life provides the most comprehensive longevity assessment.

Red Flags to Watch in Any DTC Lab Platform

Not all biomarker testing is clinically appropriate. Three pitfalls apply across platforms, including Function Health.

First, false positives from screening asymptomatic populations. When you test 100+ markers, statistical probability guarantees that 5% will fall outside the reference range by chance alone. This generates follow-up imaging, specialist referrals, and anxiety. The American Board of Internal Medicine's Choosing Wisely campaign specifically cautions against "routine general health checks for asymptomatic adults" when not tied to risk-stratified guidelines [12].

Second, reference ranges on DTC platforms may not match clinical decision thresholds. Function Health flags testosterone below 400 ng/dL, but the Endocrine Society defines hypogonadism as total testosterone below 300 ng/dL on two morning draws [3]. A patient flagged as "low" by the platform may be clinically normal.

Third, no platform replaces a physician who integrates lab data with symptoms, family history, medication interactions, and physical examination. The AHA's 2019 primary prevention guideline emphasizes that cardiovascular risk assessment requires pooling lab values (lipids, glucose) with clinical factors (blood pressure, smoking, age) into validated risk calculators like the Pooled Cohort Equations [13]. A biomarker dashboard alone does not do this.

How to Decide: A Use-Case Decision Matrix

Match your primary goal to the platform that serves it best.

"I want broad data and I have my own doctor." Function Health. The $499 annual fee buys a comprehensive panel that most PCPs will not order proactively.

"I want hormone treatment, not just hormone numbers." Marek Health or HealthRX. Both pair labs with telemedicine and prescriptions.

"I want GLP-1 therapy with integrated monitoring." HealthRX. Baseline labs, prescribing, and follow-up panels in one workflow.

"I want the cheapest guideline-concordant screening." Quest Direct. Under $150 for the markers that actually have Grade A or B USPSTF recommendations.

"I want biological age tracking with recommendations." InsideTracker. Algorithm-driven interpretation with dietary and supplement guidance.

"I want the most comprehensive longevity workup money can buy." Fountain Life. Labs plus imaging plus AI screening, for $19,500+/year.

No single platform fits every patient. The smartest move is matching your clinical need to the platform built to address it, rather than defaulting to the one with the most biomarkers.